Malin Life Sciences Holdings Limited 13D and 13G filings for Immunocore Holdings plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-07 11:37 am Sale | 2022-08-31 | 13G | Immunocore Holdings plc IMCR | Malin Life Sciences Holdings Limited | 2,109,425 4.560% | -280,554 (-11.74%) | Filing |
| 2022-02-10 4:55 pm Purchase | 2021-12-31 | 13G | Immunocore Holdings plc IMCR | Malin Life Sciences Holdings Limited | 2,389,979 5.450% | 30,554 (+1.29%) | Filing |
| 2021-10-15 1:17 pm Purchase | 2021-10-15 | 13G | Immunocore Holdings plc IMCR | Malin Life Sciences Holdings Limited | 2,359,425 5.390% | 2,359,425 (New Position) | Filing |